2013
DOI: 10.1002/phy2.70
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for the involvement of NADPH oxidase in adenosine receptor-mediated control of coronary flow using A1and A3knockout mice

Abstract: The NADPH oxidase (Nox) subunits 1, 2 (gp91 phox) and 4 are the major sources for reactive oxygen species (ROS) in cardiovascular system. In conditions such as ischemia-reperfusion injury and hypoxia, both ROS and adenosine are released suggesting a possible interaction. We hypothesized that ROS generated through Nox is involved in adenosine-induced coronary flow (CF) responses. Adenosine (10−8-10−5.5 M) increased CF in isolated hearts from wild type (WT; C57/BL6), A1 adenosine receptor (AR) knockout (A1KO), A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
23
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 15 publications
(28 citation statements)
references
References 32 publications
5
23
0
Order By: Relevance
“…Many adenine nucleotides including ATP and AMP are potent vasodilators, yet they serve no benefit in regulating MI/R injury 16. Furthermore, the vasodilation seen in coronary blood flow with adenosine has been previously reported to be dependent on upregulation of NADPH‐oxidase–mediated ROS formation in coronary endothelial cells 57, 58. In light of our findings that MSCs are capable of increasing adenosine levels while simultaneously preventing significant increases in ROS formation, it seems unlikely that vasodilation is the primary therapeutic mechanism at play.…”
Section: Discussionmentioning
confidence: 99%
“…Many adenine nucleotides including ATP and AMP are potent vasodilators, yet they serve no benefit in regulating MI/R injury 16. Furthermore, the vasodilation seen in coronary blood flow with adenosine has been previously reported to be dependent on upregulation of NADPH‐oxidase–mediated ROS formation in coronary endothelial cells 57, 58. In light of our findings that MSCs are capable of increasing adenosine levels while simultaneously preventing significant increases in ROS formation, it seems unlikely that vasodilation is the primary therapeutic mechanism at play.…”
Section: Discussionmentioning
confidence: 99%
“…However, little is known about the involvement of Nox2-derived ROS in adenosine-mediated flow response in the coronary circulation. Although activation of A 1 and A 3 AR has been shown to have vascular effects through ROS [33,36], our recent studies have already excluded the involvement of A 1 and A 3 ARs in ROS-mediated regulation of coronary flow [37]. Therefore, with the focus on the adenosine signaling, the first aim of the present study was to further investigate whether A 2A and/or A 2B AR are involved in Nox2-derived ROS-mediated coronary vasodilation.…”
Section: Introductionmentioning
confidence: 92%
“…Adenosine concentration response curves (10 −8 -10 −5 M) were acquired in perfused hearts from WT, A 2A AR KO, and A 2B AR KO mice. Each concentration of adenosine was infused for 5 min followed by a minimum of 5 min of perfusion for drug washout [16,37]. In separate experiments, the specific Nox2 inhibitor gp91 ds-tat (1 μM) [42] or the superoxide dismutase and catalase-mimicking drug EUK134 (50 μM) was perfused for 20 min before acquiring adenosine concentration response curves (10 −8 -10 −5 M) in perfused hearts from those mice [37].…”
Section: Langendorff Experimental Protocolsmentioning
confidence: 99%
See 2 more Smart Citations